Morphological Changes of Early Human Hepatocarcinogenesis

Recent advances in liver imaging, surgery, and transplantation have drawn attention to a variety of lesions that are found in chronically diseased, usually cirrhotic, livers. Several studies have established the precancerous nature of dysplastic foci and dysplastic nodules and have delineated the morphological features of small hepatocellular carcinoma. Dysplastic foci represent incidental findings on microscopic examination of hepatic specimens, whereas dysplastic nodules are detected grossly, and often radiologically. Dysplastic foci commonly consist of proliferating hepatocytes with small cell change, which is cytologically reminiscent of well-differentiated hepatocellular carcinoma. Dysplastic nodules may show evidence of cytological or structural atypia, or both, that is insufficient for the diagnosis of hepatocellular carcinoma. The evolution of dysplastic nodules to hepatocellular carcinoma within several months to a few years of follow-up is well-documented. Small hepatocellular carcinoma with indistinct margins has been identified as an early, well-differentiated neoplasm that usually measures less than 15 mm in greatest dimension. As this lesion grows larger, it may transform into nodular hepatocellular carcinoma with distinct margins.

KEYWORDS

Dysplastic focus - dysplastic nodule - liver - small cell change - small hepatocellular carcinoma

REFERENCES

• 1 Kondoh N, Wakatsuki T, Hada A et al.. Genetic and epigenetic events in human hepatocarcinogenesis.  Int J Oncol. 2001;  18 1271-1278
• 2 Bannasch P, Schroeder C H. Tumours and tumour-like lesions of the liver and biliary tract: pathogenesis of primary liver tumours. In: MacSween RNM, Burt AD, Portmann BC, et al. Pathology of the Liver, 4th ed. London; Churchill Livingstone 2002: 777-825
• 3 Feitelson M A, Sun B, Satiroglu-Tufan N L et al.. Genetic mechanisms of hepatocarcinogenesis.  Oncogene. 2002;  21 2593-2604
• 4 International Working Party . Terminology of nodular hepatocellular lesions.  Hepatology. 1995;  22 983-993
• 5 Watanabe S, Okita K, Harada T et al.. Morphologic studies of the liver cell dysplasia.  Cancer. 1983;  51 2197-2205
• 6 Zhao M, Zhang N X, Du Z Y et al.. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labeling, and their features resemble distinct grades of hepatocellular carcinoma.  Histol Histopathol. 1994;  9 73-83
• 7 Le Bail B, Bernard P H, Carles J et al.. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.  J Hepatol. 1997;  27 835-842
• 8 Su Q, Benner A, Hofmann W J et al.. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia.  Virchows Arch. 1997;  431 391-406
• 9 Makino Y, Shiraki K, Sugimoto K et al.. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.  Anticancer Res. 2000;  20 3709-3715
• 10 Adachi E, Hashimoto H, Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small liver cell dysplasia.  Cancer. 1993;  72 2902-2909
• 11 Zhao M, Zimmermann A. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma.  Histol Histopathol. 1998;  13 657-670
• 12 Marchio A, Terris B, Meddeb M et al.. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.  Mol Pathol. 2001;  54 270-274
• 13 Nakanuma Y, Hirata K. Unusual hepatocellular lesions in primary biliary cirrhosis resembling but unrelated to hepatocellular neoplasms.  Virchows Arch A Pathol Anat Histopathol. 1993;  422 17-23
• 14 Anthony P P. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In: MacSween RNM, Burt AD, Portmann BC, et al. Pathology of the Liver. 4th ed. London; Churchill Livingstone 2002: 711-775
• 15 Anthony P P, Vogel C L, Barker L F. Liver cell dysplasia: a premalignant condition.  J Clin Pathol. 1973;  26 217-223
• 16 Altmann H W. Pathology of human liver tumors. In: Remmer H, Bolt HM, Bannasch P, Popper H Primary Liver Tumors. Lancaster, UK; MTP Press 1978: 53-71
• 17 Uchida T, Miyata H, Shikata T. Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.  Arch Pathol Lab Med. 1981;  105 180-186
• 18 Nakashima T, Okuda K, Kojiro M et al.. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years.  Cancer. 1983;  51 863-877
• 19 Henmi A, Uchida T, Shikata T. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia.  Cancer. 1985;  55 2594-2599
• 20 Cohen C, Berson S D. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.  Cancer. 1986;  57 1535-1538
• 21 Rubin E M, DeRose P B, Cohen C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.  Mod Pathol. 1994;  7 677-680
• 22 Hytiroglou P, Theise N D, Schwartz M et al.. Macroregenerative nodules in a series of adult cirrhotic liver explants: Issues of classification and nomenclature.  Hepatology. 1995;  21 703-708
• 23 Lee R G, Tsamandas A C, Demetris A J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.  Hepatology. 1997;  26 1415-1422
• 24 Borzio M, Bruno S, Roncalli M et al.. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.  Gastroenterology. 1995;  108 812-817
• 25 Ganne-Carrie N, Chastang C, Chapel F et al.. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis.  Hepatology. 1996;  23 1112-1118
• 26 Libbrecht L, Craninx M, Nevens F et al.. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.  Histopathology. 2001;  39 66-73
• 27 Natarajan S, Theise N D, Thung S N et al.. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis.  Am J Surg Pathol. 1997;  21 312-318
• 28 Deugnier Y M, Charalambous P, Le Quilleuc D et al.. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.  Hepatology. 1993;  18 1363-1369
• 29 Nakanuma Y, Ohta G. Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.  Cancer. 1985;  55 2400-2404
• 30 Terada T, Terasaki S, Nakanuma Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.  Cancer. 1993;  72 1551-1556
• 31 Mion F, Grozel L, Boillot O et al.. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas.  Gastroenterology. 1996;  111 1587-1592
• 32 Furuya K, Nakamura M, Yamamoto Y et al.. Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease.  Cancer. 1988;  61 99-105
• 33 Nakanuma Y, Terada T, Terasaki S et al.. ‘Atypical adenomatous hyperplasia’ in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion?.  Histopathology. 1990;  17 27-35
• 34 Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.  Hum Pathol. 1991;  22 172-178
• 35 Ferrell L D, Crawford J M, Dhillon A P et al.. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease.  Am J Surg Pathol. 1993;  17 1113-1123
• 36 Nakanuma Y, Terada T, Ueda K et al.. Adenomatous hyperplasia of the liver as a precancerous lesion.  Liver. 1993;  13 1-9
• 37 Theise N D. Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: Theoretical and clinical considerations.  Semin Liver Dis. 1995;  15 360-371
• 38 Hytiroglou P, Theise N D. Differential diagnosis of hepatocellular nodular lesions.  Semin Diagn Pathol. 1998;  15 285-299
• 39 Ishak K G, Goodman Z D, Stocker J T. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology, 3rd series, Fascicle 31. Washington, DC; Armed Forces Institute of Pathology 2001: 185-198
• 40 Theise N D, Park Y N, Kojiro M. Dysplastic nodules and hepatocarcinogenesis.  Clin Liver Dis. 2002;  6 497-512
• 41 Terada T, Nakanuma Y, Hoso M et al.. Fatty macroregenerative nodule in non-steatotic liver cirrhosis. A morphologic study.  Virchows Arch A Pathol Anat Histopathol. 1989;  415 131-136
• 42 Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers.  Hepatology. 1989;  10 851-854
• 43 Wada K, Kondo F, Kondo Y. Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study.  Hepatology. 1988;  8 1684-1688
• 44 Theise N D, Marcelin K, Goldfischer M et al.. Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis.  Liver. 1996;  16 134-139
• 45 Terada T, Hoso M, Nakanuma Y. Mallory body clustering in adenomatous hyperplasia in human cirrhotic livers: Report of four cases.  Hum Pathol. 1989;  20 868-890
• 46 Terada T, Nakanuma Y. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions.  Arch Pathol Lab Med. 1989;  113 916-920
• 47 Arakawa M, Kage M, Sugihara S et al.. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases.  Gastroenterology. 1986;  91 198-208
• 48 Ohno Y, Shiga J, Machinami R. A histopathological analysis of five cases of adenomatous hyperplasia containing minute hepatocellular carcinoma.  Acta Pathol Jpn. 1990;  40 267-278
• 49 Eguchi A, Nakashima O, Okudaira S et al.. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma.  Hepatology. 1992;  15 843-848
• 50 Kojiro M. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint.  J Hepatobiliary Pancreat Surg. 2000;  7 535-541
• 51 Takayama T, Makuuchi M, Hirohashi S et al.. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.  Lancet. 1990;  336 1150-1153
• 52 Borzio M, Borzio F, Croce A et al.. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study.  Gastroenterology. 1997;  112 1617-1623
• 53 Sakamoto M, Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection.  Jpn J Clin Oncol. 1998;  28 604-608
• 54 Terasaki S, Kaneko S, Kobayashi K et al.. Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study.  Gastroenterology. 1998;  115 1216-1222
• 55 Seki S, Sakaguchi H, Kitada T et al.. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.  Clin Cancer Res. 2000;  6 3469-3473
• 56 Ueda K, Terada T, Nakanuma Y, Matsui O. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma. A morphometric study.  Hum Pathol. 1992;  23 619-626
• 57 Terada T, Nakanuma Y. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas.  Histopathology. 1995;  27 333-339
• 58 Park Y N, Yang C P, Fernandez G J et al.. Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver.  Am J Surg Pathol. 1998;  22 656-662
• 59 Roncalli M, Roz E, Coggi G et al.. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.  Hepatology. 1999;  30 1174-1178
• 60 Park Y N, Kim Y B, Yang K M, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.  Arch Pathol Lab Med. 2000;  124 1061-1065
• 61 Bhattacharya S, Davidson B, Dhillon A P. Blood supply of early hepatocellular carcinoma.  Semin Liver Dis. 1995;  15 390-401
• 62 Frachon S, Gouysse G, Dumortier J et al.. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.  J Hepatol. 2001;  34 850-857
• 63 Terada T, Nakanuma Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma.  Cancer. 1992;  70 591-598
• 64 Tiniakos D G, Brunt E M. Proliferative cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.  Liver. 1999;  19 58-68
• 65 Park Y N, Chae K J, Kim Y B et al.. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis.  Cancer. 2001;  92 2733-2738
• 66 Orsatti G, Theise N D, Thung S N, Paronetto F. DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature.  Hepatology. 1993;  17 621-627
• 67 Tsuda H, Hirohashi S, Shimosato Y et al.. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.  Gastroenterology. 1988;  95 1664-1666
• 68 Aihara T, Noguchi S, Sasaki Y et al.. Clonal analysis of precancerous lesion of hepatocellular carcinoma.  Gastroenterology. 1996;  111 455-461
• 69 Aihara T, Noguchi S, Sasaki Y et al.. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis.  Gastroenterology. 1994;  107 1805-1811
• 70 Paradis V, Laurendeau I, Vidaud M, Bedossa P. Clonal analysis of macronodules in cirrhosis.  Hepatology. 1998;  28 953-958
• 71 Paradis V, Dargere D, Bonvoust F et al.. Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection and HUMARA assay.  Lab Invest. 2000;  80 1553-1559
• 72 Ochiai T, Urata Y, Yamano T et al.. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus.  Hepatology. 2000;  31 615-621
• 73 Aihara T, Noguchi S, Miyoshi Y et al.. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver.  Hepatology. 1998;  28 86-89
• 74 Yamada T, De Souza A T, Finkelstein S, Jirtle R L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.  Proc Natl Acad Sci USA. 1997;  94 10351-10355
• 75 Maggioni M, Coggi G, Cassani B et al.. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.  Hepatology. 2000;  32 942-946
• 76 Sun M, Eshleman J R, Ferrell L D et al.. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.  Hepatology. 2001;  33 1415-1424
• 77 Kahng Y S, Lee Y S, Kim B K et al.. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.  J Gastroenterol Hepatol. 2003;  18 430-436
• 78 Miura N, Horikawa I, Nishimoto A et al.. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.  Cancer Genet Cytogenet. 1997;  93 56-62
• 79 Hytiroglou P, Kotoula V, Thung S N et al.. Telomerase activity in precancerous hepatic nodules.  Cancer. 1998;  82 1831-1838
• 80 Takaishi H, Kitamoto M, Takahashi S et al.. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridisation protection assay.  Cancer. 2000;  88 312-317
• 81 Youssef N, Paradis V, Ferlicot S, Bedossa P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis.  J Pathol. 2001;  194 459-465
• 82 Kotoula V, Hytiroglou P, Pyrpasopoulou A et al.. Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.  Liver. 2002;  22 57-69
• 83 Paradis V, Bieche I, Dargere D et al.. Molecular profiling of hepatocellular carcinomas using a large-scale real-time RT-PCR approach. Determination of a molecular diagnostic index.  Am J Pathol. 2003;  163 733-741
• 84 Nakanuma Y, Ohta G, Sugiura H et al.. Incidental solitary hepatocellular carcinomas smaller than 1 cm in size found at autopsy: a morphologic study.  Hepatology. 1986;  6 631-635
• 85 Kondo F, Hirooka N, Wada K, Kondo Y. Morphological clues for the diagnosis of small hepatocellular carcinomas.  Virchows Arch A Pathol Anat Histopathol. 1987;  411 15-21
• 86 Kondo F, Kondo Y, Nagato Y et al.. Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views.  J Gastroenterol Hepatol. 1994;  9 604-612
• 87 Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins.  Hepatology. 1995;  22 101-105
• 88 Kojiro M. Pathology of early hepatocellular carcinoma-progression from early to advanced.  Hepatogastroenterology. 1998;  45 1203-1205
• 89 Nakashima Y, Nakashima O, Hsia C C et al.. Vascularization of small hepatocellular carcinomas: correlation with differentiation.  Liver. 1999;  19 12-18
• 90 Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors.  Semin Liver Dis. 1999;  19 287-296
• 91 Kutami R, Nakashima Y, Nakashima O et al.. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.  J Hepatol. 2000;  33 282-289
• 92 Takayama T, Makuuchi M, Hirohashi S et al.. Early hepatocellular carcinoma as an entity with a high rate of surgical cure.  Hepatology. 1998;  28 1241-1246
• 93 Ferrell L, Wright T, Lake J et al.. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers.  Hepatology. 1992;  16 1372-1381
• 94 Esumi M, Aritaka T, Arii M et al.. Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA.  Cancer Res. 1986;  46 5767-5771
• 95 Aoki N, Robinson W S. State of hepatitis B viral genomes in cirrhotic and hepatocellular carcinoma nodules.  Mol Biol Med. 1989;  6 395-408
• 96 Sheu J C, Huang G T, Chou H C et al.. Multiple hepatocellular carcinomas at the early stage have different clonality.  Gastroenterology. 1993;  105 1471-1476
• 97 Yano H, Iemura A, Fukuda K et al.. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells.  Hepatology. 1993;  18 320-327
• 98 Sirivatanauksorn Y, Sirivatanauksorn V, Bhattacharya S et al.. Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting.  J Pathol. 1999;  189 344-350
• 99 Chuma M, Sakamoto M, Yamazaki K et al.. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.  Hepatology. 2003;  37 198-207
• 100 Theise N D, Yao J L, Harada K et al.. Hepatic ‘stem cell’ malignancies in adults: four cases.  Histopathology. 2003;  43 263-271